RPL15B Antibody

What is RPL15 and why is it significant in research?

RPL15 (Ribosomal Protein L15) is a component of the 60S large ribosomal subunit that plays a crucial role in protein synthesis. It has gained significant research attention due to its conservation across multiple species and potential involvement in various cellular processes beyond ribosome biogenesis . Recent studies indicate RPL15 overexpression in certain cancer types, particularly colon cancer, suggesting its potential role in carcinogenesis . As a ribosomal protein with both housekeeping and potential regulatory functions, RPL15 serves as an important target for investigating translational control mechanisms and their dysregulation in disease states.

What applications are RPL15 antibodies most commonly used for?

RPL15 antibodies are validated for multiple experimental applications with varying optimal conditions:

For optimal results in specific experimental systems, antibody titration is strongly recommended to determine the ideal concentration for your particular application and sample type .

How should RPL15 antibodies be stored to maintain optimal activity?

Proper storage is critical for maintaining antibody functionality over time. RPL15 antibodies are typically supplied in PBS with protective agents such as sodium azide and glycerol. The recommended storage conditions are:

• Short-term storage (up to 3 months): 4°C

• Long-term storage (up to 1 year): -20°C

• Avoid repeated freeze-thaw cycles as these can degrade antibody quality

• For antibodies supplied in glycerol solutions (e.g., with 50% glycerol), aliquoting may be unnecessary for -20°C storage

• Protect from prolonged exposure to high temperatures

Following these guidelines ensures maintained antibody reactivity and specificity throughout your research timeline.

How can I validate RPL15 antibody specificity for my experimental system?

Validating antibody specificity is essential for generating reliable scientific data. For RPL15 antibodies, consider implementing these validation strategies:

• Molecular weight verification: Compare your detected band with the expected molecular weight of RPL15. The calculated molecular weight is approximately 24 kDa, though the observed weight in SDS-PAGE is typically around 27 kDa . This discrepancy may reflect post-translational modifications or specific properties of the protein.

• Positive and negative controls: Include known positive samples (e.g., HeLa cells, K-562 cells for Western blot) and appropriate negative controls such as pre-immune serum or peptide competition assays.

• Cross-reference with orthogonal methods: Confirm protein expression using alternative techniques such as mass spectrometry or RNA-level validation with RT-PCR using primers such as:

  • Forward: 5'-GATTCGTGTTCGCCGTGGT-3'

  • Reverse: 5'- TGCTTGTGGACTGGTTTGG-3'

• Knockdown/knockout validation: When possible, use siRNA/shRNA knockdown or CRISPR/Cas9 knockout samples to demonstrate antibody specificity through signal reduction or elimination.

What antigen retrieval methods are recommended for RPL15 immunohistochemistry?

Effective antigen retrieval is critical for successful IHC staining with RPL15 antibodies. Based on validated protocols:

• Primary recommendation: TE buffer at pH 9.0

• Alternative method: Citrate buffer at pH 6.0

How should I troubleshoot weak or absent RPL15 signal in Western blots?

When facing challenges with RPL15 detection in Western blot applications, consider these systematic troubleshooting approaches:

• Sample preparation optimization:

  • Ensure complete cell lysis using appropriate buffers containing protease inhibitors

  • Confirm protein concentration using reliable quantification methods

  • Load adequate protein amounts (typically 20-50 μg total protein)

• Antibody concentration adjustment:

  • Try higher antibody concentrations within the recommended range (1:200-1:500)

  • Extend primary antibody incubation time (overnight at 4°C)

• Signal enhancement strategies:

  • Use more sensitive detection systems (e.g., enhanced chemiluminescence)

  • Consider signal amplification methods compatible with your detection system

  • Optimize blocking conditions to reduce background while preserving specific signal

• Tissue/cell-specific considerations:

  • RPL15 expression levels vary by tissue type; confirm expected expression in your sample

  • For cancer research, note that RPL15 is typically overexpressed in colon cancer cells compared to normal tissues

How is RPL15 expression altered in cancer models?

Research indicates significant alterations in RPL15 expression in certain cancer types, particularly colon cancer. Key findings include:

• Differential expression: RPL15 is frequently overexpressed in colon cancer cells and tissues compared to normal controls .

• Experimental validation: This overexpression has been confirmed through multiple methodologies:

  • Quantitative real-time PCR using specific primers

  • Western blot analysis using anti-RPL15 antibodies

  • Immunohistochemical staining of cancer tissues

• Functional significance: The elevated expression suggests potential roles beyond ribosomal function, possibly contributing to cancer progression through mechanisms that are still being elucidated.

For researchers investigating cancer models, monitoring RPL15 expression may provide insights into disease mechanisms and potential therapeutic targets.

What cross-reactivity considerations are important when studying RPL15 across different species?

RPL15 is highly conserved across species, which has important implications for antibody selection and experimental design:

• Documented reactivity: Commercial RPL15 antibodies have confirmed reactivity with:

  • Human samples (primary validation)

  • Mouse samples (validated)

  • Rat samples (validated)

  • Pig samples (cited reactivity)

• Sequence homology considerations: Due to high conservation across species (as shown in phylogenetic analyses) , antibodies raised against human RPL15 often cross-react with orthologs from other mammals.

• Application-specific validation: Despite sequence homology, always validate antibody performance in your specific species and application before conducting full-scale experiments.

When designing cross-species studies, selecting antibodies with documented multi-species reactivity increases the likelihood of successful detection while reducing the need for species-specific antibody panels.

How do different antibody formats of RPL15 compare for specialized applications?

While most commercial RPL15 antibodies are unconjugated primary antibodies, understanding the implications of different formats is important for specialized applications:

Currently available commercial RPL15 antibodies are predominantly rabbit polyclonal antibodies in unconjugated format , which offer excellent versatility across multiple applications.

What are the critical parameters for optimizing immunofluorescence with RPL15 antibodies?

Successful immunofluorescence detection of RPL15 requires careful optimization of several parameters:

• Fixation method selection:

  • Paraformaldehyde (4%) is commonly effective for RPL15 detection

  • Methanol fixation may provide superior results for some cell types

• Permeabilization optimization:

  • 0.1-0.5% Triton X-100 is typically effective

  • Adjust permeabilization time based on cell type (5-15 minutes)

• Antibody dilution titration:

  • Start with the recommended range (1:50-1:500)

  • Optimize signal-to-noise ratio for your specific cell type

• Counterstaining considerations:

  • RPL15 primarily localizes to cytoplasm and nucleoli

  • DAPI nuclear counterstain provides helpful context for localization

  • Consider co-staining with other ribosomal or nucleolar markers for colocalization studies

• Special considerations for cancer cells:

  • Cancer cells may show altered RPL15 expression levels and localization patterns

  • Compare with normal cells when investigating disease-related changes

How should I design experiments to investigate RPL15's role in ribosome biogenesis?

Investigating RPL15's function in ribosome biogenesis requires a multi-faceted experimental approach:

• Expression manipulation strategies:

  • siRNA/shRNA knockdown to reduce RPL15 levels

  • CRISPR/Cas9-mediated knockout for complete elimination

  • Overexpression systems using tagged constructs for functional studies

• Functional readouts:

  • Polysome profiling to assess ribosome assembly

  • 35S-methionine incorporation assays to measure protein synthesis rates

  • rRNA processing analysis using Northern blot or RT-PCR

• Localization studies:

  • Immunofluorescence to track RPL15 subcellular distribution using optimized antibody dilutions (1:50-1:500)

  • Co-localization with nucleolar markers to assess pre-ribosomal association

  • Live-cell imaging with fluorescently tagged RPL15 to monitor dynamics

• Interaction analyses:

  • Immunoprecipitation using RPL15 antibodies to identify binding partners

  • Mass spectrometry to characterize the RPL15 interactome

  • Proximity labeling approaches to map the local protein environment

These approaches provide complementary data to build a comprehensive understanding of RPL15's role in ribosome biogenesis and potential extraribosomal functions.

What controls are essential when interpreting RPL15 expression data in disease models?

Proper experimental controls are crucial for accurate interpretation of RPL15 expression changes in disease contexts:

• Sample-matched controls:

  • For tissue samples: Adjacent normal tissue from the same patient

  • For cell lines: Appropriate non-transformed counterparts to cancer cell lines

  • For primary cultures: Cells derived from healthy donors matched for age/sex

• Technical validation controls:

  • Multiple detection methods (protein level via Western blot, RNA level via RT-PCR)

  • Independent antibody validation using different clones targeting distinct epitopes

  • Loading controls appropriate for the experimental context (β-actin is commonly used)

• Quantification standards:

  • Inclusion of standard curves for absolute quantification

  • Use of the 2-ΔΔCt method for RT-PCR data analysis

  • Densitometric analysis of Western blots with appropriate normalization

• Statistical considerations:

  • Minimum of three independent biological replicates

  • Appropriate statistical tests for data type and distribution

  • Results should be presented as means ± standard deviations

Following these control guidelines ensures that observed changes in RPL15 expression can be confidently attributed to the biological phenomenon under investigation rather than technical artifacts.